Unverified90% confidenceCautionTime unknown
正在服用华法林、达比加群等抗凝药物者不应自行选购含K2的骨密度营养包，K2会拮抗抗凝效果影响INR
1
Sources
90%
Confidence
Long-term
Relevance
-
First Seen
Sources
Related Entities
Related Claims
Unverified正在服用华法林等香豆素类抗凝药者不建议自行补充维生素K2，K2会拮抗抗凝效果导致INR波动，必须由医生调整89% similarUnverified正在服用华法林等香豆素类抗凝药者不建议选含K2的复合配方，K2会干扰抗凝效果83% similarPartially Verified正在服用华法林等抗凝血药物的人群不宜自行使用含K2的复方产品，K2会影响凝血因子活性82% similarUnverified服用华法林等香豆素类抗凝药者不应擅自选含维K2的复合配方，K会拮抗抗凝效果81% similarUnverified正在服用华法林等抗凝血药物的人群不适合自行补充K2，需咨询医生后再决定是否使用含K2的复合片79% similar
Cite This Claim
Stable URI
https://kongchang.com/claim/160439API
curl https://kongchang.com/api/v1/knowledge/claims/160439MCP
get_claim(id=160439)